Longitudinal Morphometric Analysis of Epiretinal Membrane in Patients with Uveitis

REFERENCES

• Multicenter Uveitis Steroid Treatment Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, et al. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149(4):550–561.e10.
   PubMed Web of Science ®Google Scholar
• Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162.
   PubMed Web of Science ®Google Scholar
• Hiscott P, Hagan S, Heathcote L, et al. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye (Lond). 2002;16(4):393–403.
   Google Scholar
• Snead DR, James S, Snead MP. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye (Lond). 2008;22(10):1310–1317.
   PubMed Web of Science ®Google Scholar
• Hiscott PS, Unger WG, Grierson I, et al. The role of inflammation in the development of epiretinal membranes. Curr Eye Res. 1988;7(9):877–892.
   PubMed Web of Science ®Google Scholar
• Do DV, Cho M, Nguyen QD, et al. The impact of optical coherence tomography on surgical decision making in epiretinal membrane and vitreomacular traction. Trans Am Ophthalmol Soc. 2006;104:161–166.
   PubMedGoogle Scholar
• Legarreta JE, Gregori G, Knighton RW, et al. Three dimensional spectral-domain optical coherence tomography images of the retina in the presence of epiretinal membranes. Am J Ophthalmol. 2008;145(6):1023–1030.
   Google Scholar
• Odrobina D, Michalewska Z, Michalewski J, et al. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography. Retina. 2011;31(2):324–331.
   PubMed Web of Science ®Google Scholar
• Falkner-Radler CI, Glittenberg C, Hagen S, et al. Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology. 2010;117(4):798–805.
   PubMed Web of Science ®Google Scholar
• Nigam N, Bartsch DU, Cheng L, et al. Spectral domain optical coherence tomography for imaging ERM, retinal edema, and vitreomacular interface. Retina. 2010;30(2):246–253.
   PubMedGoogle Scholar
• Arichika S, Hangai M, Yoshimura N. Correlation between thickening of the inner and outer retina and visual acuity in patients with epiretinal membrane. Retina. 2010;30(3):503-8.
   PubMed Web of Science ®Google Scholar
• Oster SF, Mojana F, Brar M, et al. Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010;30(5):713–718.
   PubMed Web of Science ®Google Scholar
• Kaluzny JJ, Wojtkowski M, Sikorski BL, et al. Analysis of the outer retina reconstructed by high-resolution, three-dimensional spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2009;40(2):102–108.
   Google Scholar
• Landa G, Amde W, Doshi V, et al. Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration. Ophthalmologica. 2009;223(6):370–375.
   PubMed Web of Science ®Google Scholar
• Contreras I, Noval S, Rebolleda G, et al. Follow-up of nonarteritic anterior ischemic optic neuropathy with optical coherence tomography. Ophthalmology. 2007;114(12):2338–2344.
   PubMed Web of Science ®Google Scholar
• Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 2006;26(3):279–284.
   PubMed Web of Science ®Google Scholar
• Nazari H, Dustin L, Heussen FM, et al. Morphometric spectral domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis. Am J Ophthalmol. 2012;154(1):78–86.
   Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Sadda SR, Keane PA, Ouyang Y, et al. Impact of scanning density on measurements from spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51(2):1071–1078.
   Google Scholar
• Kim J, Rhee KM, Woo SJ, et al. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am J Ophthalmol. 2010;150(5):701–709.e1.
   PubMed Web of Science ®Google Scholar
• Yazici AT, Alagöz N, Celik HU, et al. Idiopathic and secondaryepiretinalmembranes: do they differ in terms of morphology? An optical coherence tomography-based study. Retina. 2011;31(4):779–784.
   Google Scholar
• Roe RH, McDonald HR, Fu AD, et al. Unexplained vision loss following removal ofepiretinal membrane. Br J Ophthalmol. 2010;94(8):1033–1039.
   Google Scholar
• Keane PA, Liakopoulos S, Jivrajka RV, et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50(7):3378–3385.
   Google Scholar
• Sugar EA, Jabs DA, Altaweel MM, et al. Identifyinga clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography. Am J Ophthalmol. 2011;152(6):1044–1052.e5.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ocampo-Dorta S, Garcia-Medina JJ, Feliciano-Sanchez A, et al. Effect of posterior capsular opacification removal on macular optical coherence tomography. Eur J Ophthalmol. 2008;18(3):435–441.
   Google Scholar